文献速递乳房整形与再造

植入物乳房再造术后假体周围感染的特征:全国健康数据库有效性评估

Characterizing infections in prosthetic breast reconstruction: A validity assessment of national health databases.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2017-05-18

该回顾性研究分析2005至2014年两家机构1820例(2980侧乳房)扩张器/假体再造患者,共发生421例假体周围感染(14%),其中早期173例(41%)、晚期248例(59%),平均感染时间66.4±101.9天;晚期感染患者吸烟或糖尿病比例更高,革兰阴性菌和耐药葡萄球菌更多见于早期感染,晚期感染导致假体丢失更常见。

要点

  • 假体乳房再造术后假体周围感染总发生率为14%,其中59%为晚期感染(>30天)。
  • 晚期感染患者更可能为当前吸烟者或患有糖尿病(p<0.034)。
  • 晚期感染导致假体丢失更常见(p=0.037)。

核心结论

  • 植入物乳房再造术后晚期假体周围感染在全国结局数据库中可能被低估,且具有不同于早期感染的危险因素和微生物学特征。
  • 鉴于晚期假体周围感染的频率和显著发病率,有必要系统性地重新评估和重新定义植入物感染的追踪与治疗时间线。

研究设计与样本

  • 回顾性分析2005至2014年两家机构所有接受扩张器/假体再造的女性患者。
  • 共纳入1820例患者(2980侧乳房),识别所有假体周围感染并分为早期(≤30天)和晚期(>30天)队列。
  • 感染定义为因临床感染证据而开始使用抗生素或取出假体装置的任一事件。

主要发现

  • 1820例患者(2980侧乳房)中共发生421例假体周围感染(14%)。
  • 173例(41%)为早期感染,248例(59%)为晚期感染,平均感染时间66.4±101.9天。
  • 晚期感染患者当前吸烟或糖尿病的比例高于早期感染患者(两者p<0.034)。
  • 革兰阴性菌和抗菌药物耐药葡萄球菌菌株引起的感染在早期感染组更常见(两者p<0.001)。
  • 因感染导致的假体丢失在晚期感染组更常见(p=0.037)。

临床怎么用

  • 临床应关注植入物乳房再造术后30天以后的晚期假体周围感染,不应仅局限于术后30天监测。
  • 对吸烟和合并糖尿病的患者,应加强晚期感染的预防和随访。
  • 早期感染更需考虑革兰阴性菌和耐药葡萄球菌,晚期感染更需警惕假体丢失风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Current guidelines in the United States require reporting only the 30-day postoperative outcomes to standardized databases, including the National Surgical Quality Improvement Program (NSQIP). Thus, many breast implant-related complications go unreported in standard databases. We sought to characterize late periprosthetic infections following implant-based breast reconstruction. METHODS: We conducted a retrospective analysis of all women who underwent expander/implant reconstruction from 2005 to 2014 at two institutions. All periprosthetic infections were identified and divided into early and late cohorts (≤30 days or >30 days). Infection was defined as any episode where antibiotics were initiated or a prosthetic device was explanted because of clinical evidence of the infection. RESULTS: In the 1820 patients (2980 breasts) identified, 421 periprosthetic infections occurred (14%). Of these, 173 (41%) were early and 248 (59%) were late (mean time to infection = 66.4 ± 101.9 days). Patients with late infections were more likely to be current smokers or have diabetes than patients with early infections (p < 0.034 for both). Infections caused by gram-negative bacteria and antimicrobial-resistant strains of Staphylococcus were more common in the early infection group (p < 0.001 for both). Implant loss due to infection was more common in the late infection group (p = 0.037). DISCUSSION: Late periprosthetic infections following implant-based breast reconstruction are underestimated in national outcome databases and have unique risk factors and microbiology compared to early infections. A system-level change in reevaluating and redefining a timeline for tracking and treating implant infections is necessary, given the substantial morbidity associated with, and frequency of, late periprosthetic infections.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Piper ML, Roussel LO, Koltz PF, et al. Characterizing infections in prosthetic breast reconstruction: A validity assessment of national health databases. J Plast Reconstr Aesthet Surg. 2017. PMID: 28619483. doi:10.1016/j.bjps.2017.05.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。